351 related articles for article (PubMed ID: 29282717)
1. Intracerebroventricular administration of Cystatin C ameliorates disease in SOD1-linked amyotrophic lateral sclerosis mice.
Watanabe S; Komine O; Endo F; Wakasugi K; Yamanaka K
J Neurochem; 2018 Apr; 145(1):80-89. PubMed ID: 29282717
[TBL] [Abstract][Full Text] [Related]
2. Cystatin C protects neuronal cells against mutant copper-zinc superoxide dismutase-mediated toxicity.
Watanabe S; Hayakawa T; Wakasugi K; Yamanaka K
Cell Death Dis; 2014 Oct; 5(10):e1497. PubMed ID: 25356866
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective Effect of Human Adipose Stem Cell-Derived Extract in Amyotrophic Lateral Sclerosis.
Jeon GS; Im W; Shim YM; Lee M; Kim MJ; Hong YH; Seong SY; Kim M; Sung JJ
Neurochem Res; 2016 Apr; 41(4):913-23. PubMed ID: 26646002
[TBL] [Abstract][Full Text] [Related]
4. A copper-deficient form of mutant Cu/Zn-superoxide dismutase as an early pathological species in amyotrophic lateral sclerosis.
Tokuda E; Nomura T; Ohara S; Watanabe S; Yamanaka K; Morisaki Y; Misawa H; Furukawa Y
Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt A):2119-2130. PubMed ID: 29551730
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effects of JGK-263 in transgenic SOD1-G93A mice of amyotrophic lateral sclerosis.
Ahn SW; Jeon GS; Kim MJ; Shon JH; Kim JE; Shin JY; Kim SM; Kim SH; Ye IH; Lee KW; Hong YH; Sung JJ
J Neurol Sci; 2014 May; 340(1-2):112-6. PubMed ID: 24680562
[TBL] [Abstract][Full Text] [Related]
6. ApoSOD1 lacking dismutase activity neuroprotects motor neurons exposed to beta-methylamino-L-alanine through the Ca
Petrozziello T; Secondo A; Tedeschi V; Esposito A; Sisalli M; Scorziello A; Di Renzo G; Annunziato L
Cell Death Differ; 2017 Mar; 24(3):511-522. PubMed ID: 28085149
[TBL] [Abstract][Full Text] [Related]
7. MicroNeurotrophins Improve Survival in Motor Neuron-Astrocyte Co-Cultures but Do Not Improve Disease Phenotypes in a Mutant SOD1 Mouse Model of Amyotrophic Lateral Sclerosis.
Glajch KE; Ferraiuolo L; Mueller KA; Stopford MJ; Prabhkar V; Gravanis A; Shaw PJ; Sadri-Vakili G
PLoS One; 2016; 11(10):e0164103. PubMed ID: 27716798
[TBL] [Abstract][Full Text] [Related]
8. MTOR-independent, autophagic enhancer trehalose prolongs motor neuron survival and ameliorates the autophagic flux defect in a mouse model of amyotrophic lateral sclerosis.
Zhang X; Chen S; Song L; Tang Y; Shen Y; Jia L; Le W
Autophagy; 2014 Apr; 10(4):588-602. PubMed ID: 24441414
[TBL] [Abstract][Full Text] [Related]
9. Early-stage treatment with Withaferin A reduces levels of misfolded superoxide dismutase 1 and extends lifespan in a mouse model of amyotrophic lateral sclerosis.
Patel P; Julien JP; Kriz J
Neurotherapeutics; 2015 Jan; 12(1):217-33. PubMed ID: 25404049
[TBL] [Abstract][Full Text] [Related]
10. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL
Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224
[TBL] [Abstract][Full Text] [Related]
11. Autophagy activation and neuroprotection by progesterone in the G93A-SOD1 transgenic mouse model of amyotrophic lateral sclerosis.
Kim J; Kim TY; Cho KS; Kim HN; Koh JY
Neurobiol Dis; 2013 Nov; 59():80-5. PubMed ID: 23891729
[TBL] [Abstract][Full Text] [Related]
12. Rilmenidine promotes MTOR-independent autophagy in the mutant SOD1 mouse model of amyotrophic lateral sclerosis without slowing disease progression.
Perera ND; Sheean RK; Lau CL; Shin YS; Beart PM; Horne MK; Turner BJ
Autophagy; 2018; 14(3):534-551. PubMed ID: 28980850
[TBL] [Abstract][Full Text] [Related]
13. Trehalose decreases mutant SOD1 expression and alleviates motor deficiency in early but not end-stage amyotrophic lateral sclerosis in a SOD1-G93A mouse model.
Li Y; Guo Y; Wang X; Yu X; Duan W; Hong K; Wang J; Han H; Li C
Neuroscience; 2015 Jul; 298():12-25. PubMed ID: 25841320
[TBL] [Abstract][Full Text] [Related]
14. n-butylidenephthalide treatment prolongs life span and attenuates motor neuron loss in SOD1
Zhou QM; Zhang JJ; Li S; Chen S; Le WD
CNS Neurosci Ther; 2017 May; 23(5):375-385. PubMed ID: 28229532
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of Abeta is associated with acceleration of onset of motor impairment and superoxide dismutase 1 aggregation in an amyotrophic lateral sclerosis mouse model.
Li QX; Mok SS; Laughton KM; McLean CA; Volitakis I; Cherny RA; Cheung NS; White AR; Masters CL
Aging Cell; 2006 Apr; 5(2):153-65. PubMed ID: 16626394
[TBL] [Abstract][Full Text] [Related]
16. Fenretinide Beneficial Effects on Amyotrophic Lateral Sclerosis-associated SOD1
Orienti I; Armida M; Dobrowolny G; Pepponi R; Sollazzini G; Pezzola A; Casola I; Musarò A; Popoli P; Potenza RL
Neuroscience; 2021 Oct; 473():1-12. PubMed ID: 34363869
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of Withania somnifera extract in SOD1
Dutta K; Patel P; Julien JP
Exp Neurol; 2018 Nov; 309():193-204. PubMed ID: 30134145
[TBL] [Abstract][Full Text] [Related]
18. Fasudil, a rho kinase inhibitor, limits motor neuron loss in experimental models of amyotrophic lateral sclerosis.
Takata M; Tanaka H; Kimura M; Nagahara Y; Tanaka K; Kawasaki K; Seto M; Tsuruma K; Shimazawa M; Hara H
Br J Pharmacol; 2013 Sep; 170(2):341-51. PubMed ID: 23763343
[TBL] [Abstract][Full Text] [Related]
19. Actions of the antihistaminergic clemastine on presymptomatic SOD1-G93A mice ameliorate ALS disease progression.
Apolloni S; Fabbrizio P; Amadio S; Volonté C
J Neuroinflammation; 2016 Aug; 13(1):191. PubMed ID: 27549088
[TBL] [Abstract][Full Text] [Related]
20. Urate mitigates oxidative stress and motor neuron toxicity of astrocytes derived from ALS-linked SOD1
Bakshi R; Xu Y; Mueller KA; Chen X; Granucci E; Paganoni S; Sadri-Vakili G; Schwarzschild MA
Mol Cell Neurosci; 2018 Oct; 92():12-16. PubMed ID: 29928993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
